New and Revised FDA Import Alerts for April 24
On April 24, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
- 99-46: Imported Human Foods due to Filth (here)
- 99-43: Ready-to-Eat Human (RTE) Food Products that appear to have been Prepared, Packed or Held Under Insanitary Conditions (here)
- 99-39: Imported Food Products that appear to be Misbranded (here)
- 99-23: Produce due to Contamination with Human Pathogens (here)
- 99-22: Foods Containing Undeclared Major Food Allergens or Foods that fail to Properly Label Major Food Allergens (here)
- 99-05: Raw Agricultural Products for Pesticides (here)
- 76-01: Medical Instruments from Pakistan (here)
- 66-79: Drugs from Foreign Establishments Refusing FDA Inspection (here)
- 66-66: APIs that appear to be Misbranded Under 502(f)(1) because they do not meet the Requirements for the Labeling Exemptions in 21 CFR 201.122 (here)
- 66-41: Unapproved New Drugs Promoted in the U.S. (here)
- 45-02: Foods Containing Illegal and/or Undeclared Colors (here)
- 16-129: Seafood Products due to Nitrofurans (here)
- 16-127: Crustaceans due to Chloramphenicol (here).